CNE1000043J1
CNE1000043J1
SANSURE BIOTECH INC
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.641.533.008 | 1.458.061.553 | 12.6% |
| Cost of Revenue | 397.479.158 | 322.054.954 | 23.4% |
| Gross Profit | 1.244.053.850 | 1.136.006.599 | 9.5% |
| 1.033.566.611 | 949.745.524 | 8.8% | |
| Operating Income | 210.487.239 | 186.261.075 | 13.0% |
| Pretax Income | 175.083.964 | 260.611.039 | 32.8% |
| Net Income Common Stockholders | 198.937.411 | 275.596.144 | 27.8% |
| -- | -- | -- | |
| -- | -- | -- |